Invokana Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Renal Mechanism of SGLT2 Inhibition
Conditions:   Type 2 Diabetes;   Diabetic Kidney Disease Interventions:   Drug: canagliflozin;   Drug: Aminohippurate Sodium Inj 20% Sponsors:   University of Colorado, Denver;   Boston Medical Center;   University of Michigan;   Brigham and Women's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2022 Category: Research Source Type: clinical trials